Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model

1 Nov 2020

Abstract excerpt

Doxorubicin (Doxo) is the most effective chemotherapeutic agent for the treatment of breast cancer. However, resistance to Doxo is common. Adjuvant compounds capable of modulating mechanisms involved in Doxo resistance may potentiate the effectiveness of the drug. Resveratrol (Rsv) has been tested as an adjuvant in mammary malignancies. However, the cellular and molecular mechanisms underlying the effects of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histone Deacetylase Inhibitors Research
Share to PARP inhibition in cancer therapy
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33204396
DOI: 10.1155/2020/5432651

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico ModelPMID 33204396Read ↗

Meta-Analysis of the Antioxidant and Antitumor Effects of Resveratrol in Animal Models of Breast Cancer: Integrative Review for Clinical Study DesignSemantic proximity Read ↗

In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell linesSemantic proximity Read ↗

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.Semantic proximity Read ↗

Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced CardiotoxicitySemantic proximity Read ↗

High throughput, Label-free, Quantitative Nanoflow Proteomic Landscape Analysis of MDA-MB-231 TNBC Cells, treated with Resveratrol and Electrical PulsesSemantic proximity Read ↗

Involvement of Epithelial to Mesenchymal Transition in Canine Mammary Tumor ProgressionSemantic proximity Read ↗

Disrupted Lipid Metabolism, Cytokine Signaling, and Dormancy: Hallmarks of Doxorubicin-Resistant Triple-Negative Breast Cancer ModelsSemantic proximity Read ↗

Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast CancerSemantic proximity Read ↗

Network integration and modelling of dynamic drug responses at multi-omics levelsSemantic proximity Read ↗

miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibitionSemantic proximity Read ↗

Identifying Representative Cell Line Models for TNBC Chemotherapy Drug Resistance via Systems Biology and BioinformaticsSemantic proximity Read ↗

Identifying key regulatory genes in drug resistance acquisition: Modeling pseudotime trajectories of single-cell transcriptomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.